Equfina Launched in S. Korea as Add-on for ‘Off’ Periods
Eisai Korea has launched Equfina (safinamide) in South Korea as an add-on therapy to levodopa for people with…
Articles by Forest Ray PhD
High Interest in Medical Cannabis as Parkinson’s Treatment, Survey Says
A survey done in Germany showed that a majority of people with Parkinson’s disease were interested in exploring medical…
Gut Fungi Not Linked to Parkinson’s Development
While scientists continue to shed light on a connection between gut bacteria and Parkinson’s disease, one study has…
Physical Inactivity Caused by Anxiety Linked to Cognitive Impairment
The more anxiety a person feels early in the course of Parkinson’s disease, the less likely that person will…
Patients Report Higher Stress, Telemedicine Use Due to COVID-19
Expanding telemedicine services and their accessibility could support people with Parkinson’s disease through the COVID-19 pandemic and beyond…
Vision Test May Predict Cognitive Decline in Parkinson’s Patients
Visual dysfunction and its underlying brain changes can identify Parkinson’s disease patients at higher risk of cognitive decline, who…
Dormant Viruses May Cause Parkinson’s
Dormant viruses lying hidden in the nervous system can give rise to Parkinson’s disease, according to a newly-published biological…
Adamas Aquires Global Rights to Osmolex ER for Motor Symptoms
Adamas Pharmaceuticals has acquired global rights to the Parkinson’s disease medication Osmolex ER (amantadine hydrochloride), used to treat…
Exercise, Hobbies Counter Effects of Sleep Disturbances During COVID-19 Lockdown
Sleep disturbances caused by home confinement during the COVID-19 pandemic are linked to worsening Parkinson’s symptoms and poorer…
MJFF Recognized for Advocacy Role in Parkinson’s Research, Public Health Policy
The Michael J. Fox Foundation (MJFF)Â has received the Advocacy/Policy Award from the Reagan-Udall Foundation for the U.S. Food and…